Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
'Essentials of Cancer Genomic, Computational Approaches and Precision Medicine [[electronic resource] /] / edited by Nosheen Masood, Saima Shakil Malik
| 'Essentials of Cancer Genomic, Computational Approaches and Precision Medicine [[electronic resource] /] / edited by Nosheen Masood, Saima Shakil Malik |
| Edizione | [1st ed. 2020.] |
| Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (XVIII, 499 p. 59 illus., 50 illus. in color.) |
| Disciplina | 616.994042 |
| Soggetto topico |
Cancer research
Oncology Human genetics Bioinformatics Nanotechnology Genètica humana Càncer Oncologia Bioinformàtica Nanotecnologia Cancer Research Oncology Human Genetics Nanotechnology and Microengineering |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 981-15-1067-9 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Module 1_ Introduction -- Module 2_ Cancer Metastasis -- Module 3_ Role of Transcriptomics in cancer treatment strategies -- Module 4_Computational approaches -- Module 5_Biostatistics and clinical oncology -- Module 6_Pharmacogenomics in cancer -- Chapter 7_Case studies. |
| Record Nr. | UNINA-9910409704903321 |
| Singapore : , : Springer Singapore : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advanced Concepts in Human Immunology: Prospects for Disease Control / / edited by Pooja Jain, Lishomwa C. Ndhlovu
| Advanced Concepts in Human Immunology: Prospects for Disease Control / / edited by Pooja Jain, Lishomwa C. Ndhlovu |
| Edizione | [1st ed. 2020.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (XVIII, 403 p. 16 illus., 5 illus. in color.) |
| Disciplina | 616.079 |
| Soggetto topico |
Immunology
Vaccines Infectious diseases Cancer research Immunologia Sistema immunitari Malalties autoimmunitàries Càncer Al·lèrgia Malalties neurodegeneratives Malalties infeccioses Vaccine Infectious Diseases Cancer Research |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-33946-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. Human Chronic Viruses: Pathogenesis, host response, and treatment -- 2. Defining the Role of Immunoproteomics in Human Immunotherapy -- 3. Microbiome and Cellular Players in Type 1 Diabetes: from Pathogenesis to Protection -- 4. Immune Mechanisms, Pathology, and Management of Allergic Ocular Diseases -- 5. Dendritic Cell-regulated T Cell Immunity and Tolerance against Acute Myeloid Leukemia -- 6. Perspectives on the Role of T cell Negative Immune Checkpoint Receptors in Health and Disease -- 7. Neuroprotective Immunity for Neurodegenerative and Neuroinfectious Diseases -- 8. Polycystic Ovary Syndrome: An overview of a complex, heterogeneous genetic condition. |
| Record Nr. | UNINA-9910416101503321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advanced machine learning approaches in cancer prognosis : challenges and applications / / Janmenjoy Nayak [and four others] editors
| Advanced machine learning approaches in cancer prognosis : challenges and applications / / Janmenjoy Nayak [and four others] editors |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (461 pages) |
| Disciplina | 006.31 |
| Collana | Intelligent systems reference library ; Volume 204. |
| Soggetto topico |
Cancer - Prognosis - Technological innovations
Machine learning Artificial intelligence - Medical applications Càncer Pronòstic mèdic Innovacions tecnològiques Intel·ligència artificial en medicina Aprenentatge automàtic |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-71975-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910482988603321 |
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antibodies for treating cancer : basics, development, and applications / / Melvyn Little
| Antibodies for treating cancer : basics, development, and applications / / Melvyn Little |
| Autore | Little Melvyn <1945-> |
| Edizione | [1st ed. 2021.] |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (XI, 151 p. 34 illus. in color.) |
| Disciplina | 616.99406 |
| Soggetto topico |
Antineoplastic antibiotics
Health Immunoglobulines Immunoteràpia Càncer |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-72599-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1 Life-saving antibodies – history of immunization -- 2 Current approaches for immunising against cancer -- 3 Function and Structure of antibodies -- 4 Of mice and men - production of therapeutic antibodies -- 5 Novel modular antibodies -- 6 Antibodies as “Magic Bullets” -- 7 Mediation of tumor cell destruction -- 8 Engagement of immune killer cells -- 9 Approved antibodies for cancer therapy -- 10 Bringing therapeutic antibodies on the market -- 11 Future developments – outlook. |
| Record Nr. | UNINA-9910482959303321 |
Little Melvyn <1945->
|
||
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Assessment of cancer screening : a primer / / Pamela M. Marcus
| Assessment of cancer screening : a primer / / Pamela M. Marcus |
| Autore | Marcus Pamela M |
| Pubbl/distr/stampa | Cham, : Springer Nature, 2022 |
| Descrizione fisica | 1 online resource (138 p.) |
| Soggetto topico |
Early Detection of Cancer
Càncer Diagnòstic Cribratge |
| Soggetto genere / forma | Llibres electrònics |
| Soggetto non controllato |
Cancer Prevention
Cancer Statistics Cancer Performance Measures Cancer Population Measures Cancer Screening Process Open Access |
| ISBN | 3-030-94577-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910558694403321 |
|
Marcus Pamela M
|
||
| Cham, : Springer Nature, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Atlas of extreme facial cancer : challenges and solutions / / Ian Burton, Michael F. Klaassen, editors
| Atlas of extreme facial cancer : challenges and solutions / / Ian Burton, Michael F. Klaassen, editors |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer International Publishing, , [2022] |
| Descrizione fisica | 1 online resource (467 pages) : color illustrations |
| Disciplina | 616.99492059 |
| Soggetto topico |
Face - Cancer - Surgery
Face - Surgery Càncer Cirurgia |
| Soggetto genere / forma |
Atles (Científic)
Llibres electrònics |
| ISBN | 3-030-88334-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910568257803321 |
| Cham, Switzerland : , : Springer International Publishing, , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer biology : how science works / / Carsten Carlberg and Eunike Velleuer
| Cancer biology : how science works / / Carsten Carlberg and Eunike Velleuer |
| Autore | Carlberg Carsten |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (179 pages) |
| Disciplina | 616.994071 |
| Soggetto topico |
Carcinogenesis
Cancer - Etiology Càncer Etiologia |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-75699-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Preface -- Acknowledgements -- Contents -- Abbreviations -- 1 Introduction to Cancer -- 1.1 The Global Burden of Cancer -- 1.2 Categorization and Diagnosis of Tumors -- 1.3 Crucial Transitions in Cancer -- 1.4 Causes of Cancer -- 1.5 Cancer Prevention -- Further Reading -- 2 Oncogenes and Signal Transduction -- 2.1 Cellular Transformation -- 2.2 Activating Oncogenes in Signal Transduction Pathways -- 2.3 Oncogenic Translocations and Amplifications -- 2.4 The Hallmarks of Cancer Concept -- Further Reading -- 3 Tumor Suppressor Genes and Cell Fate Control -- 3.1 p53 - A Master Example -- 3.2 Tumor Suppressors and Oncogenes in Cell Cycle Control -- 3.3 Tumor Suppressor Inhibition and Cancer Onset -- Further Reading -- 4 Multi-step Tumorigenesis and Genome Instability -- 4.1 Characteristics of Tumor Growth -- 4.2 Multi-step Tumorigenesis -- 4.3 Genome Instability -- 4.4 Cancer Driver Mutations and Genes -- Further Reading -- 5 Cancer Genomics -- 5.1 Human Genetic Variation and Cancer Susceptibility -- 5.2 The Cancer Genome -- 5.3 Cancer Genome Projects -- Further Reading -- 6 Cancer Epigenomics -- 6.1 Epigenetic Mechanisms of Cancer -- 6.2 DNA Methylation and Cancer -- 6.3 Chromatin Changes and Cancer -- 6.4 Epigenetic Reprogramming in Cancer -- Further Reading -- 7 Aging and Cancer -- 7.1 Central Role of Aging During Chronic Diseases -- 7.2 The Hallmarks of Aging -- 7.3 Epigenetics of Aging -- 7.4 Telomeres and Replicative Immortality -- Further Reading -- 8 Tumor Microenvironment -- 8.1 The Impact of the Wound Healing Program for Cancer -- 8.2 Cell Types of the Tumor Microenvironment -- 8.3 Inducing Angiogenesis -- 8.4 Tumor-Promoting Inflammation -- 8.5 Deregulating Cellular Energetics -- Further Reading -- 9 Metastasis and Cachexia -- 9.1 The Metastatic Cascade -- 9.2 Epithelial-Mesenchymal Transition -- 9.3 Metastatic Colonization.
9.4 Cachexia -- Further Reading -- 10 Cancer Immunity -- 10.1 Outline of Cancer Immunity -- 10.2 Recognition of Tumor Antigens -- 10.3 Monoclonal Antibodies in Cancer Immunotherapy -- 10.4 Immune Cell Therapies -- Further Reading -- 11 Architecture of Cancer Therapies -- 11.1 Classical Cancer Treatments -- 11.2 Targeted Therapies -- 11.3 Precision Oncology -- Further Reading -- Glossary. |
| Record Nr. | UNINA-9910490024603321 |
|
Carlberg Carsten
|
||
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer biomarkers in diagnosis and therapeutics / / edited by Adeeb Shehzad
| Cancer biomarkers in diagnosis and therapeutics / / edited by Adeeb Shehzad |
| Pubbl/distr/stampa | Singapore : , : Springer, , [2022] |
| Descrizione fisica | 1 online resource (372 pages) |
| Disciplina | 616.994075 |
| Soggetto topico |
Cancer - Diagnosis
Càncer Marcadors bioquímics Diagnòstic |
| Soggetto genere / forma | Llibres electrònics |
| ISBN |
981-16-5758-0
981-16-5759-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910743224703321 |
| Singapore : , : Springer, , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer diagnostics and therapeutics : current trends, challenges, and future perspectives / / S. K. Basu, Chinmay Kumar Panda, Subrata Goswami, editors
| Cancer diagnostics and therapeutics : current trends, challenges, and future perspectives / / S. K. Basu, Chinmay Kumar Panda, Subrata Goswami, editors |
| Pubbl/distr/stampa | Singapore : , : Springer, , [2022] |
| Descrizione fisica | 1 online resource (525 pages) |
| Disciplina | 616.994075 |
| Soggetto topico |
Cancer - Diagnosis
Cancer - Treatment Càncer Diagnòstic |
| Soggetto genere / forma | Llibres electrònics |
| ISBN |
981-16-4752-6
981-16-4751-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Preface -- Acknowledgements -- Contents -- Editors and Contributors -- About the Editors -- Contributors -- Part I: Basic Background -- 1: Fighting with Cancer: A Common Man´s Dilemma -- 1.1 Cancer -- 1.2 Types and Terminologies -- 1.3 Some Statistics -- 1.4 Role of Various Physicians and Nursing Care and the Available Treatment Options -- 1.4.1 Surgery -- 1.4.2 Chemotherapy -- 1.4.2.1 Radiotherapy -- 1.4.3 Cancer Pain Management and Palliative Care -- 1.5 Coping with Cancer Diagnosis and Treatments -- 1.6 Rays of Hope -- 1.7 Winning and Fighting Cancer -- 1.8 Conclusion -- References -- 2: Cell Biology and Cell Behavior in Cancer -- 2.1 Introduction -- 2.1.1 Eukaryotic Cell Structure -- 2.1.1.1 Cell Membrane -- 2.1.1.2 Cytoplasm -- Organic Molecules -- Organelles -- Organelles with Double Membranes -- NucleusNucleus -- Nuclear MembraneNuclear Membrane -- NeoplasmNeoplasm -- NucleolusNucleolus -- ChromosomeChromosome -- MitochondrionMitochondrion -- ChloroplastsChloroplasts -- Organelles with Single Membrane -- PeroxisomePeroxisome -- Endoplasmic ReticulumEndoplasmic Reticulum -- Golgi ApparatusGolgi Apparatus -- LysosomeLysosome -- 2.1.2 Cell Cycle -- 2.1.2.1 Basic Structure of DNA and Its Function -- 2.1.2.2 Eukaryotic Chromosome -- 2.1.2.3 Replication and Repairing of DNA -- 2.1.2.4 DNA Recombination -- 2.1.2.5 DNA Transcription -- 2.1.2.6 Cell Division -- Mitosis -- Meiosis -- 2.1.2.7 Basics of Heredity -- 2.1.2.8 Intracellular Signaling -- 2.2 Introduction to Cancer Biology -- 2.2.1 Factors Playing Behind Cancer -- 2.2.2 Hallmarks of Cancer -- 2.2.3 Classification of Cancer -- 2.2.4 Cancer Detection and Diagnosis -- 2.3 Conclusion -- References -- 3: Tumor Biology: An Introduction -- 3.1 Introduction: Cancer Perspective from Fundamental Biology -- 3.2 The Nature of Cancer and Its Types.
3.3 Environmental Insults-Mutagens, Carcinogens, and Cancer-Causing Mutations -- 3.4 Infectious Agents, Inflammation, and Cancer -- 3.5 Cellular and Genetic Basis of Cancer -- 3.5.1 Comparison of Cancer Cell and Normal Cell -- 3.5.2 Genetic View of Cancer -- 3.5.3 Tumorigenesis -- 3.5.4 Oncogenes and Tumor Suppressor Genes -- 3.5.5 Genome-Wide Approach -- 3.6 Temporal Variation of Cancer Incidence Rate in Different Populations -- 3.7 Prevention and Early Detection -- 3.8 Conclusion -- References -- 4: Role of Angiogenesis in Tumors -- 4.1 Introduction -- 4.2 Mechanisms of Angiogenesis -- 4.2.1 Angiogenesis from Endothelial Precursor Cells (EPCs) -- 4.2.2 Angiogenic Switch -- 4.3 Angiogenesis in Physiologic Processes -- 4.4 Angiogenesis in the Pathogenesis of Cancer -- 4.5 Angiogenesis: A Network of Signaling Pathways -- 4.5.1 Endogenous Pro-angiogenic Factors -- 4.5.2 VEGF -- 4.6 Angiogenesis Ahead of VEGF/VEGFR Pathway -- 4.6.1 Platelet-Derived Growth Factor (PDGF)/PDGFR -- 4.6.2 Fibroblast Growth Factor (FGF)/FGFR -- 4.6.3 Angiopoietins (Ang)/Tie2 -- 4.6.4 Hepatocyte Growth Factor (HGF)/MET -- 4.7 Inhibitors of Angiogenesis -- 4.7.1 Angiostatin -- 4.7.2 Endostatin -- 4.7.3 Thrombospondins (TSPs) -- 4.8 Angiogenesis and Cancer -- 4.8.1 Anti-Angiogenic Treatment of Cancer -- 4.9 Combinatorial Targeting of Multiple Pro-angiogenic Pathways: An Alternative to Overcome Resistance -- 4.10 Current and Emerging Multi-Targeting Anti-Angiogenic Agents -- 4.11 Our Research Endeavors -- 4.12 Conclusions -- References -- 5: Biology, Chemistry, and Physics of Cancer Cell Motility and Metastasis -- 5.1 Introduction -- 5.2 Biological Background -- 5.2.1 Equilibrium in Cell Population -- 5.2.2 Oncogene and Tumor Suppressor Genes -- 5.2.3 Cellular Adhesion -- 5.2.4 Cell Signaling -- 5.3 Cancer Cell Motility and Metastasis: Biology and Chemistry. 5.3.1 Cancer Cell Motility -- 5.3.1.1 RhoGTPase Family -- 5.3.1.2 Single Cell Motility -- 5.3.1.3 Motility of Collective Cells -- 5.3.2 Metastasis -- 5.3.2.1 Proteolytic Enzymes -- 5.3.2.2 Adhesion Proteins -- 5.4 Physical and Mechanical Processes in Cell Motility and Metastasis -- 5.4.1 Physical Interaction in Cell Motility -- 5.4.2 Cellular Mechanics in Intravasation -- 5.4.3 Forces Acting on the Circulating Tumor Cells -- 5.4.4 Extravasation of Circulating Tumor Cells -- 5.4.4.1 Receptor-Ligand Interactions of Circulating Tumor Cells -- 5.4.4.2 Physics behind the Location of Metastatic Site -- 5.5 Conclusions -- Appendix -- Biological Notes -- References -- Part II: Diagnostics and Theory -- 6: MRI, CT, and PETSCAN: Engineer´s Perspective -- 6.1 Introduction -- 6.2 Tomographic Imaging in Medical Diagnosis: Historical Developments -- 6.3 Magnetic Resonance Imaging (MRI) -- 6.3.1 The Machine: A Gigantic Chamber -- 6.3.2 Magnetic Moment -- 6.3.3 Nuclear Magnetic Moment -- 6.3.4 Classical Precession -- 6.3.5 Total Magnetization -- 6.3.6 Radiofrequency Pulse: Related Magnetization -- 6.4 MR Signal Detection -- 6.4.1 MR Signal Intensity -- 6.4.2 Relaxation: Spin-Lattice (T1) and Spin-Spin (T2) -- 6.4.3 Magnetic Gradient Coils -- 6.4.4 K-Space and Image Formation -- 6.4.5 Pulse Sequence -- 6.5 Computed Tomography -- 6.5.1 Basics of X-ray -- 6.5.2 Diagnostic Application of Radiography -- 6.5.3 Limitations of Radiography -- 6.6 Basic Principle of Computed Tomography -- 6.6.1 Image Viewing System -- 6.7 Components of CT Scanner -- 6.7.1 X-Ray Detector and Data Acquisition System -- 6.8 Reconstruction of CT Image -- 6.9 Evolution of CT Scanning Technology -- 6.9.1 First-Generation CT (Translate-Rotate Mode) -- 6.9.2 Second-Generation CT (Multidetector Translate-Rotate Mode) -- 6.9.3 Third-Generation CT (Rotate-Rotate Mode). 6.9.4 Fourth-Generation CT (Fixed-Rotate) -- 6.9.5 Electron Beam CT (Fixed-Fixed) -- 6.9.6 Helical CT -- 6.10 Clinical Application of CT Scan Image -- 6.11 PET Scan -- 6.12 PET Scan: Basic Principle -- 6.12.1 PET Scan Utilities -- 6.12.2 Early Detection of Malignant Tumors/Cancers -- 6.13 Conclusion -- References -- 7: Diffusion, MRI, and Cancer Diagnosis: Physicist´s Outlook -- 7.1 Introduction -- 7.2 Diffusion -- 7.2.1 Phenomenological Notion and Fick´s Laws of Diffusion -- 7.2.2 Molecular Backgrounds of Diffusion and Random Walk Model -- 7.2.3 Self-Diffusion -- 7.2.3.1 Self-Diffusion and Einstein´s MSD Relation -- 7.2.4 Anisotropic Self-Diffusion -- 7.3 MRI -- 7.3.1 NMR in the Context of MRI -- 7.3.1.1 Relaxation Effects -- 7.3.1.2 The Bloch Equation and Time Evolution of Bulk Magnetization -- 7.3.1.3 An Outline of the Basic Pulsed-NMR Experiment -- 7.3.1.4 Signal-to-Noise Ratio (SNR) -- 7.3.1.5 FID Signal s(t) to NMR Spectrum S(Omega) and Fourier Transformation -- 7.3.1.6 Measurements of Relaxation Times -- 7.3.1.7 Inverse Recovery (IR) Method for Measuring T1 -- 7.3.1.8 Spin-Echo (SE) Method and Measurement of T2 -- 7.3.1.9 Effects of Diffusion on Spin-Echo Signal -- 7.3.2 NMR Imaging: MRI -- 7.3.2.1 MRI of Our Body Organs -- 7.3.2.2 The Gradient Pulses -- 7.3.2.3 The ``Receiver or Detector System´´ of an MRI Unit -- 7.3.2.4 Image Contrast -- 7.3.2.5 Basic Components of a Standard MRI System -- 7.3.3 Diffusion MRI -- 7.3.3.1 Diffusion-Weighted Imaging (DWI) -- 7.3.3.2 The Stejskal and Tanner´s Pulsed-Field Gradient Spin-Echo (PFG-SE) Sequence -- 7.3.3.3 Apparent Diffusion Coefficient Mapping (ADC Mapping): Quantitative Analysis with DWI -- 7.3.3.4 High-Speed Diffusion Imaging: Use of Echo-Planar Imaging (EPI) -- 7.3.3.5 Diffusion Tensor Imaging (DTI) -- 7.3.3.6 Indices of Anisotropic Diffusion -- 7.3.3.7 Application Potential of DTI. 7.4 Cancer -- 7.4.1 Interpretation of DWI and Its Assessment -- 7.4.2 Clinical DWI in the Body: Some Technical Issues -- 7.4.3 Applications of DWI-ADC Mapping of Target Organs -- 7.4.3.1 Detection of Tumors -- 7.4.3.2 Characterization of Tumors -- 7.4.4 Distinguishing Tumors from Non-Tumors -- 7.4.4.1 Monitoring Treatment Response -- 7.4.4.2 Predicting Treatment Response -- 7.5 Conclusions -- Appendix -- References -- 8: Oncology: Radiation Oncologist´s View -- 8.1 Introduction -- 8.1.1 Historical Perspectives -- 8.2 Mechanism of Action of Radiation and the Biological Basis of Radiation Therapy -- 8.2.1 DNA Damage -- 8.2.2 Biological Basis for Radiation Therapy -- 8.3 Principles of Radiotherapy -- 8.4 Types of Radiation -- 8.4.1 Ionising Radiation -- 8.4.2 Ionising Electromagnetic Radiation -- 8.4.3 X-Rays -- 8.4.4 Gamma (γ) Rays -- 8.4.5 Ionising Particulate Radiation -- 8.5 Units Used in Radiation Oncology -- 8.6 Basics of Radiation Protection -- 8.7 Techniques of Radiotherapy -- 8.7.1 Conventional Radiotherapy (2D Technique) -- 8.7.2 Three-Dimensional Conformal Radiation Therapy (3DCRT) -- 8.7.2.1 The Planning Process of 3DCRT -- 8.7.3 IMRT: Intensity-Modulated Radiation Therapy (IMRT) -- 8.7.3.1 Planning System of IMRT -- 8.7.4 Image-Guided Radiation Therapy (IGRT) -- 8.7.4.1 Rationale for Image-Guided Radiation Therapy -- 8.7.5 Stereotactic Radiosurgery and Radiotherapy (SRS and SRT) -- 8.7.6 Volumetric Modulated Arc Therapy (VMAT) -- 8.7.7 Surface-Guided Radiation Therapy (SGRT) -- 8.7.8 Brachytherapy -- 8.8 Fractionation in Radiotherapy -- 8.8.1 Types of Fractionation in Radiotherapy -- 8.9 Side Effects of Radiation -- 8.9.1 Early Effects (Acute Effects) -- 8.9.2 Late Effects -- 8.10 Conclusions -- References -- 9: Oncology: Biochemists´ Perspective -- 9.1 Introduction -- 9.2 Causes of Cancer -- 9.3 Development of Cancer -- 9.3.1 Initiation. 9.3.2 Promotion. |
| Record Nr. | UNINA-9910743343503321 |
| Singapore : , : Springer, , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer Drug Delivery Systems Based on the Tumor Microenvironment [[electronic resource] /] / edited by Yasuhiro Matsumura, David Tarin
| Cancer Drug Delivery Systems Based on the Tumor Microenvironment [[electronic resource] /] / edited by Yasuhiro Matsumura, David Tarin |
| Edizione | [1st ed. 2019.] |
| Pubbl/distr/stampa | Tokyo : , : Springer Japan : , : Imprint : Springer, , 2019 |
| Descrizione fisica | 1 online resource (XI, 325 p. 118 illus., 73 illus. in color.) |
| Disciplina | 615.19 |
| Soggetto topico |
Pharmaceutical technology
Cancer research Nanoscale science Nanoscience Nanostructures Pharmaceutical Sciences/Technology Cancer Research Nanoscale Science and Technology Càncer Tecnologia farmacèutica |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 4-431-56880-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Preface -- Part I Cancer pathophysiology -- 1. The Cancer Stroma and its relevance to tumor survival -- 2. Cancer and blood coagulation -- 3. Tumor Blood Vessels as targets for cancer therapy -- 4. Stromal barriers within the tumor microenvironment and obstacles to nanomedicine -- Part II Antibody drug conjugates (ADC) -- 1. Recent progress in linker technology for antibody-drug conjugates: Methods for connection and release -- 2. Preclinical studies of ADC therapy for solid tumors -- 3. ADCs on the market and in clinical development -- Part III Hybrid techniques of active and passive targeting -- 1. Micelles conjugated with a pilot molecule -- 2. Liposomes conjugated with a pilot molecule -- 3. Multifunctional Envelope-type Nano Devices (MEND) for cancer therapy -- Part IV Cancer stromal targeting (CAST) therapy and diagnosis -- 1. Principle of CAST -- 2. CAST therapy -- 3. CAST diagnosis -- Part V The Current Status of Cancer Drug Delivery Systems and Future Directions -- Index. |
| Record Nr. | UNINA-9910373901303321 |
| Tokyo : , : Springer Japan : , : Imprint : Springer, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Soggetto topico
-
Càncer
(62)
- Cancer Research (18)
- Cancer research (17)
- Oncology (13)
- Cancer (10)